Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Liabilities and Shareholders Equity (2016 - 2025)

Phibro Animal Health has reported Liabilities and Shareholders Equity over the past 13 years, most recently at $1.4 billion for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $1.4 billion for Q4 2025, up 9.34% from a year ago — trailing twelve months through Dec 2025 was $5.5 billion (up 29.82% YoY), and the annual figure for FY2025 was $1.4 billion, up 38.56%.
  • Liabilities and Shareholders Equity for Q4 2025 was $1.4 billion at Phibro Animal Health, up from $1.4 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for PAHC hit a ceiling of $1.4 billion in Q4 2025 and a floor of $805.0 million in Q1 2021.
  • Median Liabilities and Shareholders Equity over the past 5 years was $965.9 million (2023), compared with a mean of $1.0 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: grew 0.18% in 2024 and later surged 43.39% in 2025.
  • Phibro Animal Health's Liabilities and Shareholders Equity stood at $849.0 million in 2021, then rose by 13.3% to $961.8 million in 2022, then rose by 1.13% to $972.7 million in 2023, then skyrocketed by 32.16% to $1.3 billion in 2024, then increased by 9.34% to $1.4 billion in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $1.4 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.4 billion (Q2 2025) per Business Quant data.